Samsara Sciences, a subsidiary of Organovo Holdings and a provider of highly specialized human liver cells, has entered a non-exclusive global supply agreement with Lonza Bioscience Solutions. Under the terms of the agreement, Lonza will market human cell products from Samsara for further distribution to its customers. “We’re incredibly pleased to begin this partnership with Lonza, which allows us to tap into their outstanding global sales and marketing capabilities and expand the...